Nanosensors Can Scan Blood for Cancer Biomarkers-This has been achieved in whole blood for the first time
A team of experts at the Yale University has recently announced that it has developed a new series of nanosensors, a class of devices that is able to analyze whole blood samples, and detect the presence of cancer biomarkers in them. The latter are chemical agents that tumors and cancer cells produce, and their existence in the body can only mean one thing. The amazing achievement could soon enable physicians to cut the cancer-detection process short, leaving more time for the actual treatments.